earnings
confidence high
sentiment neutral
materiality 0.70
Sight Sciences Q2 2025 revenue $19.6M (-8% YoY), raises FY25 revenue guidance to $72-76M
Sight Sciences, Inc.
2025-Q2 EPS reported
-$0.51
revenue$37,072,000
- Net loss $11.9M ($0.23 loss per share) vs $12.3M loss in prior year.
- Surgical Glaucoma revenue $19.2M (-5% YoY); ordering accounts hit record 1,174, up 4%.
- Dry Eye revenue fell to $0.3M from $1.1M as company focuses on reimbursed TearCare access.
- Adjusted operating expenses $24.4M, down 8% YoY; reaffirmed FY25 guidance of $101-105M.
- Tariff exposure on China products reduced from prior estimate of $3.5-4.5M to $1.0-1.5M for FY25.
item 2.02item 7.01item 9.01